Mike Celano

Track

Insider profile

Currently holds positions in Kensey Nash Corp and OraSure Technologies Inc

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 58% 68% 82%
Transactions
3 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer Kensey Nash Corp March 10, 2009 -
Independent Chairman of the Board OraSure Technologies Inc April 1, 2018 -
Chief Operating Officer, Secretary Recro Pharma Inc Jan. 3, 2018 - May 14, 2019
Independent Director OraSure Technologies Inc Oct. 5, 2006 - April 1, 2018
Chief Financial Officer Recro Pharma Inc July 5, 2016 - Jan. 3, 2018
Mike Celano's trades of Larimar Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-05-18 2023-05-17
B Purchase
24,229 +24.0%
475.02
US$1,569,495 		24,229 +24.0% 475.02 US$1,569,495
2022-09-19 2022-09-16
B Purchase
78,795 -12.1%
457.04
US$565,323 		78,795 -12.1% 457.04 US$565,323
2022-08-16 2022-08-12
B Purchase
93,321 -15.4%
41.04
US$3,971,136 		93,321 -15.4% 41.04 US$3,971,136